Complement Med. 2018;24(4):361–8. https://pubmed.ncbi.nlm.nih.gov/29185780/

5336

Farokhnia M, Shafiee Sabet M, Iranpour N, et al. Comparing the efficacy and safety of Crocus sativus L. with memantine in patients with moderate to severe Alzheimer’s disease: a double-blind randomized clinical trial. Hum Psychopharmacol. 2014;29(4):351–9. https://pubmed.ncbi.nlm.nih.gov/25163440/

5337

Hausenblas HA, Heekin K, Mutchie HL, Anton S. A systematic review of randomized controlled trials examining the effectiveness of saffron (Crocus sativus L.) on psychological and behavioral outcomes. J Integr Med. 2015;13(4):231–40. https://pubmed.ncbi.nlm.nih.gov/26165367/

5338

Ayati Z, Yang G, Ayati MH, Emami SA, Chang D. Saffron for mild cognitive impairment and dementia: a systematic review and meta-analysis of randomised clinical trials. BMC Complement Med Ther. 2020;20(1):333. https://pubmed.ncbi.nlm.nih.gov/33167948/

5339

Tóth B, Hegyi P, Lantos T, et al. The efficacy of saffron in the treatment of mild to moderate depression: a meta-analysis. Planta Med. 2019;85(1):24–31. https://pubmed.ncbi.nlm.nih.gov/30036891/

5340

Tabeshpour J, Sobhani F, Sadjadi SA, et al. A double-blind, randomized, placebo-controlled trial of saffron stigma (Crocus sativus L.) in mothers suffering from mild-to-moderate postpartum depression. Phytomedicine. 2017;36:145–52. https://pubmed.ncbi.nlm.nih.gov/29157808/

5341

Finley JW, Gao S. A perspective on Crocus sativus L. (saffron) constituent crocin: a potent water-soluble antioxidant and potential therapy for Alzheimer’s disease. J Agric Food Chem. 2017;65(5):1005–20. https://pubmed.ncbi.nlm.nih.gov/28098452/

5342

World Health Organization. WHO Monographs on Selected Medicinal Plants. Vol 3. World Health Organization; 2001. https://apps.who.int/iris/handle/10665/42052

5343

Block BR, Albanese SG, Hume AL. Online promotion of “brain health” supplements. Sr Care Pharm. 2021;36(10):489–92. https://pubmed.ncbi.nlm.nih.gov/34593090/

5344

Goodwill AM, Szoeke C. A systematic review and meta-analysis of the effect of low vitamin D on cognition. J Am Geriatr Soc. 2017;65(10):2161–8. https://pubmed.ncbi.nlm.nih.gov/28758188/

5345

Kalra A, Teixeira AL, Diniz BS. Association of vitamin D levels with incident all-cause dementia in longitudinal observational studies: a systematic review and meta-analysis. J Prev Alzheimers Dis. 2020;7(1):14–20. https://pubmed.ncbi.nlm.nih.gov/32010921/

5346

Orces C, Lorenzo C, Guarneros JE. The prevalence and determinants of vitamin D inadequacy among U.S. older adults: National Health and Nutrition Examination Survey 2007–2014. Cureus. 2019;11(8):e5300. https://pubmed.ncbi.nlm.nih.gov/31579639/

5347

Riaz S, Malcangio M, Miller M, Tomlinson DR. A vitamin D3 derivative (CB1093) induces nerve growth factor and prevents neurotrophic deficits in streptozotocin-diabetic rats. Diabetologia. 1999;42(11):1308–13. https://pubmed.ncbi.nlm.nih.gov/10550414/

5348

Durk MR, Han K, Chow ECY, et al. 1a,25-Dihydroxyvitamin D3 reduces cerebral amyloid-ß accumulation and improves cognition in mouse models of Alzheimer’s disease. J Neurosci. 2014;34(21):7091–101. https://pubmed.ncbi.nlm.nih.gov/24849345/

5349

Hu J, Jia J, Zhang Y, Miao R, Huo X, Ma F. Effects of vitamin D3 supplementation on cognition and blood lipids: a 12-month randomised, double-blind, placebo-controlled trial. J Neurol Neurosurg Psychiatry. 2018;89(12):1341–7. https://pubmed.ncbi.nlm.nih.gov/30279212/

5350

Jia J, Hu J, Huo X, Miao R, Zhang Y, Ma F. Effects of vitamin D supplementation on cognitive function and blood Aß-related biomarkers in older adults with Alzheimer’s disease: a randomised, double-blind, placebo-controlled trial. J Neurol Neurosurg Psychiatry. 2019;90(12):1347–52. https://pubmed.ncbi.nlm.nih.gov/31296588/

5351

Castle M, Fiedler N, Pop LC, et al. Three doses of vitamin D and cognitive outcomes in older women: a double-blind randomized controlled trial. J Gerontol A Biol Sci Med Sci. 2020;75(5):835–42. https://pubmed.ncbi.nlm.nih.gov/30951148/

5352

Schietzel S, Fischer K, Brugger P, et al. Effect of 2000 IU compared with 800 IU vitamin D on cognitive performance among adults age 60 years and older: a randomized controlled trial. Am J Clin Nutr. 2019;110(1):246–53. https://pubmed.ncbi.nlm.nih.gov/31152541/

5353

Pettersen JA. Does high dose vitamin D supplementation enhance cognition?: a randomized trial in healthy adults. Exp Gerontol. 2017;90:90–7. https://pubmed.ncbi.nlm.nih.gov/28167237/

5354

Dysken MW, Sano M, Asthana S, et al. Effect of vitamin E and memantine on functional decline in Alzheimer disease: the TEAM-AD VA Cooperative Randomized Trial. JAMA. 2014;311(1):33–44. https://pubmed.ncbi.nlm.nih.gov/24381967/

5355

Sano M, Ernesto C, Thomas RG, et al. A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer’s disease. N Engl J Med. 1997;336(17):1216–22. https://pubmed.ncbi.nlm.nih.gov/9110909/

5356

Lloret A, Badía MC, Mora NJ, Pallardó FV, Alonso MD, Viña J. Vitamin E paradox in Alzheimer’s disease: it does not prevent loss of cognition and may even be detrimental. J Alzheimers Dis. 2009;17(1):143–9. https://pubmed.ncbi.nlm.nih.gov/19494439/

5357

Yaffe K, Clemons TE, McBee WL, Lindblad AS. Impact of antioxidants, zinc, and copper on cognition in the elderly: a randomized, controlled trial. Neurology. 2004;63(9):1705–7. https://pubmed.ncbi.nlm.nih.gov/15534261/

5358

Heart Protection Study Collaborative Group. MRC/BHF Heart Protection Study of antioxidant vitamin supplementation in 20,536 high-risk individuals: a randomised placebo-controlled trial. Lancet. 2002;360(9326):23–33. https://pubmed.ncbi.nlm.nih.gov/12114036/

5359

Grodstein F, O’Brien J, Kang JH, et al. Long-term multivitamin supplementation and cognitive function in men: a randomized trial. Ann Intern Med. 2013;159(12):806–14. https://pubmed.ncbi.nlm.nih.gov/24490265/

5360

Maylor EA, Simpson EEA, Secker DL, et al. Effects of zinc supplementation on cognitive function in healthy middle-aged and older adults: the ZENITH study. Br J Nutr. 2006;96(4):752–60. https://pubmed.ncbi.nlm.nih.gov/17010236/

5361

Yaffe K, Clemons TE, McBee WL, Lindblad AS. Impact of antioxidants, zinc, and copper on cognition in the elderly: a randomized, controlled trial. Neurology. 2004;63(9):1705–7. https://pubmed.ncbi.nlm.nih.gov/15534261/

5362

Kern J, Kern S, Blennow K, et al. Calcium supplementation and risk of dementia in women with cerebrovascular disease. Neurology. 2016;87(16):1674–80. https://pubmed.ncbi.nlm.nih.gov/27534711/

5363

Obeid R, Herrmann W. Mechanisms of homocysteine neurotoxicity in neurodegenerative diseases with special reference to dementia. FEBS Lett. 2006;580(13):2994–3005. https://pubmed.ncbi.nlm.nih.gov/16697371/

5364

Rutjes AWS, Denton DA, Di Nisio M, et al. Vitamin and mineral supplementation for maintaining cognitive function in cognitively healthy people in mid and